Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
about
DDX3, a potential target for cancer treatmentDEAD box RNA helicase functions in cancerEarly therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopyRecurrent read-through fusion transcripts in breast cancer.Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer.Death receptor 5 expression is inversely correlated with prostate cancer progression.Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenografts.Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancerCharacterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.Effect of niclosamide on basal-like breast cancers.Breast cancer proteome takes more than two to tango on TRAIL: beat them at their own game.Therapeutic targets in triple negative breast cancer.A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models.(DEAD)-box RNA helicase 3 modulates NF-κB signal pathway by controlling the phosphorylation of PP2A-C subunit.Low/negative expression of DDX3 might predict poor prognosis in non-smoker patients with oral cancer.Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.Tumor necrosis factor-related apoptosis inducing ligand overexpression and Taxol treatment suppresses the growth of cervical cancer cells in vitro and in vivo.212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.
P2860
Q26779054-3AED8789-CFBF-41FD-A046-7CD1864AF9D6Q27026107-F9A98151-AC76-4D56-8AE2-948F95E8B944Q30682911-E8EEBC0C-7BDB-4B3B-9F72-3512203A5249Q33858203-EF31A92A-2466-4BDB-A30F-DF255C9CD820Q33989940-763C2B64-AC18-48A0-9312-9C99DAE4D5B5Q34426868-9A5AEFBC-87AA-485D-A22C-40799C636D80Q35028823-B581863A-363D-4926-9028-75D4E607B53CQ36414044-8B81FA3C-4357-4136-A83B-D88CB69C3E69Q37066527-63D9469C-EED4-4C50-A29E-BD5E5A9B06A2Q37695022-CF173AC0-7149-48B8-9160-DB05522EAE8BQ38035209-C0363DD9-CD75-471A-A741-DA399B4D2608Q38084287-23641A29-FF57-4194-B3CA-8938908223B5Q38820739-5E91C6E2-2984-4E88-81BB-E80C325FD915Q40246228-32154E26-7B9F-4707-AA71-FE9200589BCCQ44724402-EFCD3556-66E8-4234-BFA7-F33AC9BB8DD2Q51042741-2F16FF08-707D-4BF5-B100-8BB36985B6D5Q52583854-4E488299-7CA2-46F2-B992-F01172FB5749Q52647703-6D116281-A4AC-4298-8222-852F3DCF3FABQ55042518-00EE1D5A-590B-4F9C-8869-122B764EE875
P2860
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
@ast
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
@en
type
label
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
@ast
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
@en
prefLabel
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
@ast
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
@en
P2093
P2860
P1476
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
@en
P2093
Albert F LoBuglio
Andres Forero
Choo H Lee
Donald J Buchsbaum
Guihua Zhai
Hyunki Kim
Kurt R Zinn
Patsy G Oliver
P2860
P2888
P304
P356
10.1007/S10549-011-1755-0
P407
P577
2011-09-07T00:00:00Z